亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

對(duì)乙酰胺基苯磺酰氯

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
過期 長(zhǎng)期有效
更新 2012-03-07 16:53
 

武漢市南沖醫(yī)藥化學(xué)制造科技有限公司

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明
對(duì)乙酰胺基苯磺酰氯 CAS:121-60-8
產(chǎn)品說明:

英文名稱: N-Acetylsulfanilyl chloride 別 名: 4-Acetamidobenzenesulfonyl chloride;ASC           分 子 式: C8H8ClNO3S 分 子 量: 233.66 含 量: 98.5% CAS 號(hào): 121-60-8 熔 點(diǎn): 147-148.5℃

性質(zhì):對(duì)乙酰胺基苯磺酰氯為淺灰色的針狀結(jié)晶,略有醋酸氣味,常用氯仿和二氯乙烷作重結(jié)晶溶劑。溶于乙醇和乙醚,在水中分解。

用途:對(duì)乙酰胺基苯磺酰氯廣泛應(yīng)用于染料、醫(yī)藥、農(nóng)藥、主要用于制備結(jié)晶磺胺(Sulfanilamide)、磺酰脲(Sulfanilylurea)、磺胺托拉米(Sulfatolamide)、磺胺硫脲(Sulphathiourea)、磺胺脒(Sulfaguanidine)、磺胺醋酰(Sulfacetamide)等近40個(gè)磺胺類藥物。

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
常山酮 維生素C 硫酸氫氯吡格雷 黃霉素 N-羥基丁二酰亞胺 3,3-二甲基戊二酸 葉枯酞 氨基噻唑乙酸
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |